Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cuvitru what class of drug?

See the DrugPatentWatch profile for Cuvitru

What class is Cuvitru (immune globulin) in?

Cuvitru is a brand of subcutaneous immunoglobulin (SCIg), which is made from human plasma. It belongs to the immunoglobulin (antibody) replacement therapy drug class—specifically intravenous/subcutaneous immune globulin products used to replace missing antibodies in certain immune deficiencies.

What is it used for?

Cuvitru is typically prescribed for patients who need antibody replacement due to primary immunodeficiency (for example, common variable immunodeficiency/Bruton’s agammaglobulinemia) and related conditions where the body does not make enough antibodies.

Is it an IV drug or a subcutaneous injection?

Cuvitru is given under the skin (subcutaneous infusion), which is why it’s classified as subcutaneous immune globulin rather than intravenous immune globulin.

Sources
1. DrugPatentWatch.com – Cuvitru (immune globulin) information



Other Questions About Cuvitru :

Cuvitru clinical trials? Cuvitru clinical trials? Cuvitru clinical trials? Cuvitru clinical trials? Cuvitru clinical trials?